FDA Clearance Tracker · N970012-S161
AMS Ambicor Inflatable Penile Prosthesis
Last checked: Nov 20, 2026Latest source record: Mar 28, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Mar 28, 2019
Approved
Time to decision
16 days
Received Mar 12, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- N970012-S161
- Device name
- AMS Ambicor Inflatable Penile Prosthesis
- Applicant
- Boston Scientific Corp
- Applicant location
- Marlboro, MA
- Received
- Mar 12, 2019
- Decided
- Mar 28, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- N970012
Device type
- Device type
- Prosthesis, penis, inflatable (JCW)
- Device class
- Class III
- Regulation
- 21 CFR 876.3350
- Specialty
- GI, Urology & Nephrology
FDA's approval statement
As written in FDA's record.
Approval for a sterilization site change for approval of BSC Coventry, Rhode Island as an additional sterilization site for ethylene oxide (EO) Cycle 101 due to the closure of the Sterigenics Willowbrook facility.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.